127 related articles for article (PubMed ID: 37283769)
1. Genetically predicted vitamin C levels significantly affect patient survival and immunotypes in multiple cancer types.
Yuan J; Zhang YH; Hua X; Hong HQ; Shi W; Liu KX; Liu ZX; Huang P
Front Immunol; 2023; 14():1177580. PubMed ID: 37283769
[TBL] [Abstract][Full Text] [Related]
2. [A pan-cancer analysis of TTC9A expression level and its correlation with prognosis and immune microenvironment].
Yao Y; Liu J; Zhou X; Liu Z; Qiu S; He Y; Zhou X
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jan; 44(1):70-82. PubMed ID: 38293978
[TBL] [Abstract][Full Text] [Related]
3. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
4. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
5. Systematic pan-cancer analyses of the potential function of the Golgi scaffold protein PAQR3.
Ling ZN; Hong LL; Wu J; Ling ZQ
Sci Rep; 2024 Feb; 14(1):3030. PubMed ID: 38321173
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value and immunological role of PDCD1 gene in pan-cancer.
Miao Y; Wang J; Li Q; Quan W; Wang Y; Li C; Wu J; Mi D
Int Immunopharmacol; 2020 Dec; 89(Pt B):107080. PubMed ID: 33069926
[TBL] [Abstract][Full Text] [Related]
7. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
Guo B; Wang Y; Liu W; Zhang S
Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
[TBL] [Abstract][Full Text] [Related]
8. LncRNA WAC-AS1 expression in human tumors correlates with immune infiltration and affects prognosis.
Wang Y; Gong H; Cao Y
Hereditas; 2023 May; 160(1):26. PubMed ID: 37248547
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity.
Liu T; Yang K; Chen J; Qi L; Zhou X; Wang P
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830695
[TBL] [Abstract][Full Text] [Related]
10. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
Front Immunol; 2021; 12():646523. PubMed ID: 33679809
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
[TBL] [Abstract][Full Text] [Related]
12. Pancancer analysis of the correlations of HS6ST2 with prognosis, tumor immunity, and drug resistance.
Chen W; Li X; Jiang Y; Ni D; Yang L; Wu J; Gao M; Wang J; Song J; Shi W
Sci Rep; 2023 Nov; 13(1):19209. PubMed ID: 37932473
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Value and Immunological Role of STEAP1 in Pan-Cancer: A Result of Data-Based Analysis.
Zhao C; Xiong K; Ji Z; Liu F; Li X
Oxid Med Cell Longev; 2022; 2022():8297011. PubMed ID: 35313641
[TBL] [Abstract][Full Text] [Related]
14. Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis.
Gao ZW; Yang L; Liu C; Wang X; Guo WT; Zhang HZ; Dong K
Front Immunol; 2022; 13():903461. PubMed ID: 35663977
[TBL] [Abstract][Full Text] [Related]
15. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
16. SERPINH1 is a Potential Prognostic Biomarker and Correlated With Immune Infiltration: A Pan-Cancer Analysis.
Wang Y; Gu W; Wen W; Zhang X
Front Genet; 2021; 12():756094. PubMed ID: 35058967
[No Abstract] [Full Text] [Related]
17. A Pan-Cancer Analysis of the Oncogenic Role of
Yang D; Li H; Chen Y; Li C; Ren W; Huang Y
Front Genet; 2022; 13():906174. PubMed ID: 35910232
[No Abstract] [Full Text] [Related]
18. Pan-cancer analysis of forkhead box Q1 as a potential prognostic and immunological biomarker.
Dong Q; Yan L; Xu Q; Hu X; Yang Y; Zhu R; Xu Q; Yang Y; Wang B
Front Genet; 2022; 13():944970. PubMed ID: 36118871
[TBL] [Abstract][Full Text] [Related]
19. Pan-cancer analysis reveals sex-specific signatures in the tumor microenvironment.
Han J; Yang Y; Li X; Wu J; Sheng Y; Qiu J; Wang Q; Li J; He Y; Cheng L; Zhang Y
Mol Oncol; 2022 Jun; 16(11):2153-2173. PubMed ID: 35229456
[TBL] [Abstract][Full Text] [Related]
20. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
[Next] [New Search]
